Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check6 days agoChange DetectedThe record history now includes the new release revision v3.6.3, replacing the previous v3.6.2. This reflects a software update to the ClinicalTrials.gov interface rather than changes to study data.SummaryDifference0.1%

- Check13 days agoChange DetectedRecord History now shows a new revision entry for v3.6.2, replacing the previous v3.6.0 in the version list.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status updated to no longer looking for participants. The history now includes a new revision entry (v3.6.0) to document this update.SummaryDifference0.4%

- Check35 days agoChange DetectedThe history now includes a new entry for Revision: v3.5.5, and the previous Revision: v3.5.4 entry has been removed, reflecting a small platform update to the record history display.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision tag moved from v3.5.3 to v3.5.4, indicating a new version of the record history. This reflects an update to the page's metadata rather than changes to the underlying study data.SummaryDifference0.1%

- Check70 days agoChange DetectedThe Record History shows the latest revision updated to v3.5.3, replacing the previous v3.5.2. This indicates a new version of the study record has been published.SummaryDifference0.1%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.